Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan(R)

Company expects to commence U.S. pivotal trial in late 2021 ISFIYA, Israel, March 15, 2021 -- (Healthcare Sales & Marketing Network) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage ... Devices, Gastroenterology, FDA Check-Cap, C-Scan, X-ray capsule, colorectal cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news